Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction.

MLA

Pandey, Arjun K., et al. “Mechanisms of Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction.” European Heart Journal, vol. 44, no. 37, Oct. 2023, pp. 3640–51. EBSCOhost, https://doi.org/10.1093/eurheartj/ehad389.

APA

Pandey, A. K., Bhatt, D. L., Pandey, A., Marx, N., Cosentino, F., Pandey, A., & Verma, S. (2023). Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. European Heart Journal, 44(37), 3640–3651. https://doi.org/10.1093/eurheartj/ehad389

Chicago

Pandey, Arjun K, Deepak L Bhatt, Avinash Pandey, Nikolaus Marx, Francesco Cosentino, Ambarish Pandey, and Subodh Verma. 2023. “Mechanisms of Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction.” European Heart Journal 44 (37): 3640–51. doi:10.1093/eurheartj/ehad389.